SCHEMBL4754840

SCHEMBL4754840

CC(C)(C)c1ncc(C(C)(C)C)c(C(C)(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25086286 0.85 ASPH (0.30)
SCHEMBL20618611 0.85 ASPH (0.33)
SCHEMBL21341302 0.77 NUDT1 (0.32)
SCHEMBL18073610 0.77
SCHEMBL15483458 0.77
SCHEMBL21101478 0.76 NUDT1 (0.30)
SCHEMBL20618610 0.76
SCHEMBL15483447 0.76
SCHEMBL24033682 0.76 ALOX5AP (0.30)
SCHEMBL18701569 0.76 ALDH1A1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250074932-A1 CATALYTIC STEREOSELECTIVE GLYCOSYLATION PURDUE RESEARCH FOUNDATION 2025-03-06 US claimed
US-20230046329-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. 2023-02-16 US claimed
EP-3694853-A1 PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE Array BioPharma Inc. (US) 2020-08-19 EP claimed
US-10745419-B2 Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile LOXO ONCOLOGY INC. (US) 2020-08-18 US claimed
CN-111263760-A Process for the preparation of 6- (2-hydroxy-2-methylpropoxy) -4- (6- (6- ((6-methoxypyridin-3-yl) methyl) -3, 6-diazabicyclo [3.1.1] hept-3-yl) pyridin-3-yl) pyrazolo [1, 5-a ] pyridine-3-carbonitrile 奥瑞生物药品公司 2020-06-09 CN claimed
WO-2019075092-A1 PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE EARY CHARLES TODD (US) 2019-04-18 WO claimed
US-20190106438-A1 PROCESS FOR THE PREPARATION OF 6-(2-HYDROXY-2-METHYLPROPOXY)-4-(6-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO[3.1.1]HEPTAN-3-YL)PYRIDIN-3-YL)PYRAZOLO[1,5-A]PYRIDINE-3-CARBONITRILE LOXO ONCOLOGY, INC. 2019-04-11 US claimed
US-9868755-B2 Reagent-controlled stereoselective glycosylation TRUSTEES OF TUFTS COLLEGE (US) 2018-01-16 US claimed
US-20170051003-A1 REAGENT-CONTROLLED STEREOSELECTIVE GLYCOSYLATION NATIONAL SCIENCE FOUNDATION 2017-02-23 US claimed
US-9403862-B2 Reagent controlled stereoselective glycosylation TRUSTEES OF TUFTS COLLEGE (US) 2016-08-02 US claimed
US-9359394-B2 Stereoselective glycosylation reactions TRUSTEES OF TUFTS COLLEGE (US) 2016-06-07 US claimed
US-20150038689-A1 Reagent-Controlled Stereoselective Glycosylation NATIONAL SCIENCE FOUNDATION 2015-02-05 US claimed
US-20140303359-A1 Stereoselective Glycosylation Reactions TRUSTEES OF TUFTS COLLEGE (US) 2014-10-09 US claimed
US-12486250-B2 Muscarinic receptor 4 antagonists and methods of use NEUROCRINE BIOSCIENCES, INC. (US) 2025-12-02 US disclosed
EP-4069697-B1 CRF RECEPTOR ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES INC (US) 2025-07-16 EP disclosed
US-20250074932-A1 CATALYTIC STEREOSELECTIVE GLYCOSYLATION PURDUE RESEARCH FOUNDATION 2025-03-06 US disclosed
WO-2006131616-A1 NEW TYPE OF MOLECULAR JUNCTION BETWEEN A SEMICONDUCTOR AND A METAL MICHELET DANIEL (FR) 2006-12-14 WO disclosed
US-20050233985-A1 Rsk inhibitors and therapeutic uses thereof UNIVERSITY OF VIRGINIA 2005-10-20 US disclosed
EP-1539781-A2 RSK INHIBITORS AND THERAPEUTIC USES THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2005-06-15 EP disclosed
WO-2003105766-A2 RSK INHIBITORS AND THERAPEUTIC USES THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-12-24 WO disclosed